{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:36:53Z","timestamp":1787020613749,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["306031"],"award-info":[{"award-number":["306031"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Circulating miRNAs have emerged as promising biomarker candidates due to their stability and their role in regulating key pathological pathways in cardiovascular disease (CVD). Yet, large-scale, multicentre studies examining their diagnostic and prognostic potential are scarce. This study evaluates the potential of miRNA expression profiles to inform disease classification and risk stratification across major CVD phenotypes, including acute coronary syndrome (ACS), chronic coronary artery disease (CAD), dilated cardiomyopathy (DCM), and ischemic cardiomyopathy (ICM), in a large, multicentre European cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed genome-wide miRNA expression profiles in a total of 1209 cardiovascular patients and 848 controls in a uniform, standardized fashion, which renders this study one of the largest prospective miRNA studies. To focus on only the most biologically plausible miRNAs for clinical translation, we mined all original studies of miRNA candidates in CVD and performed differential miRNA expression and enrichment analysis. We then trained disease-specific binary classification models to evaluate the diagnostic potential of miRNA signatures. Finally, we evaluated prognosis and disease severity based on distinct miRNA levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six hundred thirty four original abstracts were identified, detailing 166 ACS, 181 CAD, 56 DCM, and 182 ICM miRNAs. Without further optimization, the signatures of a priori miRNAs already yielded very good diagnostic performance with ROC AUC of 0.83\u20130.95. There was an improvement when considering additional miRNAs in a discovery setting. Interestingly, in ACS, CAD, and DCM, we observed a significantly worse prognosis in probands with higher miRNA-derived disease probabilities, indicating an association with prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The European BestAgeing miRNA study reveals emerging associations of several miRNA signatures with cardiovascular disease discrimination and prognostication, providing a foundation for future external validation and potential clinical translation of this class of markers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-025-04502-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T02:45:12Z","timestamp":1764297912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The European BestAgeing Study on microRNA candidates reveals distinct signatures with diagnostic and prognostic potential in cardiovascular disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Christoph","family":"Reich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Kayvanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Sedaghat-Hamedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Amr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ueltzh\u00f6ffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Monserrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Metspalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maris","family":"Alver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarmo","family":"Annilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Parkhomenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Kozhukhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Katus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Meder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"4502_CR1","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah GA, Fuster V, Murray CJL, Roth GA, Abate YH, Abbasian M, et al. Global burden of cardiovascular diseases and risks, 1990\u20132022. J Am Coll Cardiol. 2023;82:2350\u2013473. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.007.","journal-title":"J Am Coll Cardiol"},{"key":"4502_CR2","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145:E153-639. https:\/\/doi.org\/10.1161\/CIR.0000000000001052.","journal-title":"Circulation"},{"key":"4502_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling H, Fabbri M, Calin GA. Micrornas and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12:847\u201365. https:\/\/doi.org\/10.1038\/nrd4140.","journal-title":"Nat Rev Drug Discov"},{"key":"4502_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/aps.2018.30","volume":"39","author":"SS Zhou","year":"2018","unstructured":"Zhou SS, Jin JP, Wang JQ, Zhang ZG, Freedman JH, Zheng Y, et al. MiRNAs in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges review-article. Acta Pharmacol Sin. 2018;39:1073\u201384. https:\/\/doi.org\/10.1038\/aps.2018.30.","journal-title":"Acta Pharmacol Sin"},{"key":"4502_CR5","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.jacc.2016.09.945","volume":"68","author":"T Barwari","year":"2016","unstructured":"Barwari T, Joshi A, Mayr M. MicroRNAs in Cardiovascular Disease. J Am Coll Cardiol. 2016;68:2577\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"4502_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1152\/physrev.00006.2010","volume":"91","author":"D Sayed","year":"2011","unstructured":"Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev. 2011;91:827\u201387. https:\/\/doi.org\/10.1152\/physrev.00006.2010.","journal-title":"Physiol Rev"},{"key":"4502_CR7","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating micrornas as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513\u20138. https:\/\/doi.org\/10.1073\/pnas.0804549105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4502_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012418-012827","volume":"14","author":"PV Halushka","year":"2019","unstructured":"Halushka PV, Goodwin AJ, Halushka MK. Opportunities for microRNAs in the crowded field of cardiovascular biomarkers. Annu Rev Pathol Mech Dis. 2019;14:211\u201338. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012827.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"4502_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cpr.12262","volume":"49","author":"B Ortiz-Quintero","year":"2016","unstructured":"Ortiz-Quintero B. Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Prolif. 2016;49:281\u2013303. https:\/\/doi.org\/10.1111\/cpr.12262.","journal-title":"Cell Prolif"},{"key":"4502_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/cvr\/cvz302","volume":"116","author":"A Kaur","year":"2020","unstructured":"Kaur A, Mackin ST, Schlosser K, Wong FL, Elharram M, Delles C, et al. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease. Cardiovasc Res. 2020;116:1113\u201324. https:\/\/doi.org\/10.1093\/cvr\/cvz302.","journal-title":"Cardiovasc Res"},{"key":"4502_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11070962","volume":"11","author":"AV Zhelankin","year":"2021","unstructured":"Zhelankin AV, Stonogina DA, Vasiliev SV, Babalyan KA, Sharova EI, Doludin YV, et al. Circulating extracellular mirna analysis in patients with stable cad and acute coronary syndromes. Biomolecules. 2021;11:1\u201321. https:\/\/doi.org\/10.3390\/biom11070962.","journal-title":"Biomolecules"},{"key":"4502_CR12","doi-asserted-by":"publisher","unstructured":"Zhang L, Ding H, Zhang Y, Wang Y, Zhu W, Li P. Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction. Front Physiol. 2020;11. https:\/\/doi.org\/10.3389\/fphys.2020.01088.","DOI":"10.3389\/fphys.2020.01088"},{"key":"4502_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.119.314937","volume":"125","author":"C Schulte","year":"2019","unstructured":"Schulte C, Barwari T, Joshi A, Theofilatos K, Zampetaki A, Barallobre-Barreiro J, et al. Comparative analysis of circulating noncoding RNAs versus protein biomarkers in the detection of myocardial injury. Circ Res. 2019;125:328\u201340. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.314937.","journal-title":"Circ Res"},{"key":"4502_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/ehjacc\/zuaa034","volume":"10","author":"M Biener","year":"2021","unstructured":"Biener M, Giannitsis E, Thum T, B\u00e4r C, Costa A, Andrzejewski T, et al. Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2021;10:653\u201360. https:\/\/doi.org\/10.1093\/ehjacc\/zuaa034.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"4502_CR15","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1093\/eurheartj\/eht256","volume":"34","author":"B Vogel","year":"2013","unstructured":"Vogel B, Keller A, Frese KS, Leidinger P, Sedaghat-Hamedani F, Kayvanpour E, et al. Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure. Eur Heart J. 2013;34:2812\u201323. https:\/\/doi.org\/10.1093\/eurheartj\/eht256.","journal-title":"Eur Heart J"},{"key":"4502_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines8120597","volume":"8","author":"Y D\u2019Alessandra","year":"2020","unstructured":"D\u2019Alessandra Y, Chiesa M, Carena MC, Beltrami AP, Rizzo P, Buzzetti M, et al. Differential role of circulating micrornas to track progression and pre-symptomatic stage of chronic heart failure: A pilot study. Biomedicines. 2020;8:1\u201312. https:\/\/doi.org\/10.3390\/biomedicines8120597.","journal-title":"Biomedicines"},{"key":"4502_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","volume":"60","author":"A Zampetaki","year":"2012","unstructured":"Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, et al. Prospective study on circulating microRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012;60:290\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2012.03.056.","journal-title":"J Am Coll Cardiol"},{"key":"4502_CR18","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/ehf2.13371","volume":"8","author":"A Galluzzo","year":"2021","unstructured":"Galluzzo A, Gallo S, Pardini B, Birolo G, Fariselli P, Boretto P, et al. Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing. ESC Heart Fail. 2021;8:2907\u201319. https:\/\/doi.org\/10.1002\/ehf2.13371.","journal-title":"ESC Heart Fail"},{"key":"4502_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00161","author":"A Peterlin","year":"2020","unstructured":"Peterlin A, Po\u010divav\u0161ek K, Petrovi\u010d D, Peterlin B. The role of microRNAs in heart failure: a systematic review. Front Cardiovasc Med. 2020. https:\/\/doi.org\/10.3389\/fcvm.2020.00161.","journal-title":"Front Cardiovasc Med"},{"key":"4502_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ejhf.495","volume":"18","author":"EL Vegter","year":"2016","unstructured":"Vegter EL, Van Der Meer P, De Windt LJ, Pinto YM, Voors AA. Micrornas in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016;18:457\u201368. https:\/\/doi.org\/10.1002\/ejhf.495.","journal-title":"Eur J Heart Fail"},{"key":"4502_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ehf2.14153","volume":"10","author":"P Gargiulo","year":"2023","unstructured":"Gargiulo P, Marzano F, Salvatore M, Basile C, Buonocore D, Parlati ALM, et al. MicroRNAs: diagnostic, prognostic and therapeutic role in heart failure\u2014a review. ESC Heart Fail. 2023;10:753\u201361. https:\/\/doi.org\/10.1002\/ehf2.14153.","journal-title":"ESC Heart Fail"},{"key":"4502_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ejhf.984","volume":"20","author":"A Bay\u00e9s-Genis","year":"2018","unstructured":"Bay\u00e9s-Genis A, Lanfear DE, de Ronde MWJ, Lup\u00f3n J, Leenders JJ, Liu Z, et al. Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients. Eur J Heart Fail. 2018;20:67\u201375. https:\/\/doi.org\/10.1002\/ejhf.984.","journal-title":"Eur J Heart Fail"},{"key":"4502_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Cheng HH, Tewari M. Microrna profiling: approaches and considerations. Nat Rev Genet. 2012;13:358\u201369. https:\/\/doi.org\/10.1038\/nrg3198.","journal-title":"Nat Rev Genet"},{"key":"4502_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","volume":"57","author":"JS McDonald","year":"2011","unstructured":"McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011;57:833\u201340. https:\/\/doi.org\/10.1373\/clinchem.2010.157198.","journal-title":"Clin Chem"},{"key":"4502_CR25","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44:3865\u201377. https:\/\/doi.org\/10.1093\/nar\/gkw116.","journal-title":"Nucleic Acids Res"},{"key":"4502_CR26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamaoncol.2020.0001","volume":"6","author":"T Fehlmann","year":"2020","unstructured":"Fehlmann T, Kahraman M, Ludwig N, Backes C, Galata V, Keller V, et al. Evaluating the use of circulating microRNA profiles for lung cancer detection in symptomatic patients. JAMA Oncol. 2020;6:714\u201323. https:\/\/doi.org\/10.1001\/jamaoncol.2020.0001.","journal-title":"JAMA Oncol"},{"key":"4502_CR27","doi-asserted-by":"crossref","unstructured":"Friedrich J, Hammes H-P, Krenning G. miRetrieve: miRNA Text Mining in Abstracts. 2021. https:\/\/cran.r-project.org\/web\/packages\/miRetrieve\/index.html.","DOI":"10.32614\/CRAN.package.miRetrieve"},{"key":"4502_CR28","doi-asserted-by":"publisher","unstructured":"de Gonzalo-Calvo D, Karaduzovic-Hadziabdic K, Dalgaard LT, Dieterich C, Perez-Pons M, Hatzigeorgiou A, et al. Machine learning for catalysing the integration of noncoding RNA in research and clinical practice. EBioMedicine. 2024;106. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105247.","DOI":"10.1016\/j.ebiom.2024.105247"},{"key":"4502_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45:5\u201332.","journal-title":"Mach Learn"},{"key":"4502_CR30","first-page":"1","volume":"20","author":"A Fisher","year":"2019","unstructured":"Fisher A, Rudin C, Dominici F. All models are wrong, but many are useful: learning a variable\u2019s importance by studying an entire class of prediction models simultaneously. J Mach Learn Res. 2019;20:1\u201381.","journal-title":"J Mach Learn Res"},{"key":"4502_CR31","doi-asserted-by":"publisher","first-page":"W319","DOI":"10.1093\/nar\/gkad392","volume":"51 1 W","author":"E Aparicio-Puerta","year":"2023","unstructured":"Aparicio-Puerta E, Hirsch P, Schmartz GP, Kern F, Fehlmann T, Keller A. MiEAA 2023: Updates, new functional microRNA sets and improved enrichment visualizations. Nucleic Acids Res. 2023;51 1 W:W319-25. https:\/\/doi.org\/10.1093\/nar\/gkad392.","journal-title":"Nucleic Acids Res."},{"key":"4502_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells11030588","volume":"11","author":"KA Kott","year":"2022","unstructured":"Kott KA, Bishop M, Yang CHJ, Plasto TM, Cheng DC, Kaplan AI, et al. Biomarker Development in Cardiology: Reviewing the Past to Inform the Future. Cells. 2022;11:1\u201327. https:\/\/doi.org\/10.3390\/cells11030588.","journal-title":"Cells"},{"key":"4502_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00395-010-0123-2","volume":"106","author":"B Meder","year":"2011","unstructured":"Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol. 2011;106:13\u201323. https:\/\/doi.org\/10.1007\/s00395-010-0123-2.","journal-title":"Basic Res Cardiol"},{"issue":"18","key":"4502_CR34","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231\u201364. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038.","journal-title":"J Am Coll Cardiol"},{"key":"4502_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/CIRCGENETICS.113.000077","volume":"6","author":"Y Devaux","year":"2013","unstructured":"Devaux Y, Vausort M, McCann GP, Zangrando J, Kelly D, Razvi N, et al. Microrna-150: a novel marker of left ventricular remodeling after acute myocardial infarction. Circ Cardiovasc Genet. 2013;6:290\u20138. https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000077.","journal-title":"Circ Cardiovasc Genet"},{"key":"4502_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1536\/IHJ.18-306","volume":"60","author":"X Lin","year":"2019","unstructured":"Lin X, Zhang S, Huo Z. Serum circulating miR-150 is a predictor of post-acute myocardial infarction heart failure. Int Heart J. 2019;60:280\u20136. https:\/\/doi.org\/10.1536\/IHJ.18-306.","journal-title":"Int Heart J"},{"key":"4502_CR37","doi-asserted-by":"publisher","unstructured":"Aonuma T, Moukette B, Kawaguchi S, Barupala NP, Sep\u00falveda MN, Frick K, et al. MiR-150 Attenuates Maladaptive Cardiac Remodeling Mediated by Long Noncoding RNA MIAT and Directly Represses Profibrotic Hoxa4. Circ Heart Fail. 2022;15(4):e008686. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008686. Epub 2022 Jan 10.","DOI":"10.1161\/CIRCHEARTFAILURE.121.008686"},{"key":"4502_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05982-y","volume":"14","author":"S Kawaguchi","year":"2023","unstructured":"Kawaguchi S, Moukette B, Sep\u00falveda MN, Hayasaka T, Aonuma T, Haskell AK, et al. SPRR1A is a key downstream effector of MiR-150 during both maladaptive cardiac remodeling in mice and human cardiac fibroblast activation. Cell Death Dis. 2023;14:1\u201313. https:\/\/doi.org\/10.1038\/s41419-023-05982-y.","journal-title":"Cell Death Dis"},{"key":"4502_CR39","doi-asserted-by":"publisher","unstructured":"Aonuma T, Moukette B, Kawaguchi S, Barupala NP, Sep\u00falveda MN, Corr C, et al. Cardiomyocyte microRNA-150 confers cardiac protection and directly represses proapoptotic small proline\u2013rich protein 1A. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.150405.","DOI":"10.1172\/jci.insight.150405"},{"key":"4502_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13098-022-00942-6","volume":"14","author":"Y Ma","year":"2022","unstructured":"Ma Y, Liu H, Wang Y, Xuan J, Gao X, Ding H, et al. Roles of physical exercise-induced MiR-126 in cardiovascular health of type 2 diabetes. Diabetol Metab Syndr. 2022;14:1\u201315. https:\/\/doi.org\/10.1186\/S13098-022-00942-6.","journal-title":"Diabetol Metab Syndr"},{"key":"4502_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2023.04.013","volume":"113","author":"O Martinez-Arroyo","year":"2023","unstructured":"Martinez-Arroyo O, Ortega A, Flores-Chova A, Sanchez-Garcia B, Garcia-Garcia AB, Chaves FJ, et al. High miR-126-3p levels associated with cardiovascular events in a general population. Eur J Intern Med. 2023;113:49\u201356.","journal-title":"Eur J Intern Med"},{"key":"4502_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12872-024-04063-Y\/FIGURES\/6","volume":"24","author":"J Luo","year":"2024","unstructured":"Luo J, Wang L, Cui C, Chen H, Zeng W, Li X. MicroRNA-19a-3p inhibits endothelial dysfunction in atherosclerosis by targeting JCAD. BMC Cardiovasc Disord. 2024;24:1\u201313. https:\/\/doi.org\/10.1186\/S12872-024-04063-Y\/FIGURES\/6.","journal-title":"BMC Cardiovasc Disord"},{"key":"4502_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09530-1","volume":"10","author":"F Gao","year":"2019","unstructured":"Gao F, Kataoka M, Liu N, Liang T, Huang ZP, Gu F, et al. Therapeutic role of miR-19a\/19b in cardiac regeneration and protection from myocardial infarction. Nat Commun. 2019;10:1\u201315. https:\/\/doi.org\/10.1038\/s41467-019-09530-1.","journal-title":"Nat Commun"},{"key":"4502_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S13205-019-1812-7","volume":"9","author":"L Li","year":"2019","unstructured":"Li L, Chen Q, Feng C, Jin Y, Xia S. Aberrant expression of TNRC6a and miR-21 during myocardial infarction. 3 Biotech. 2019;9:1\u20136. https:\/\/doi.org\/10.1007\/S13205-019-1812-7.","journal-title":"3 Biotech."},{"key":"4502_CR45","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. Microrna-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980\u20134.","journal-title":"Nature"},{"key":"4502_CR46","doi-asserted-by":"publisher","first-page":"767064","DOI":"10.3389\/fcvm.2021.767064","volume":"8","author":"Surina","year":"2021","unstructured":"Surina, Fontanella RA, Scisciola L, Marfella R, Paolisso G, Barbieri M. miR-21 in Human Cardiomyopathies. Front Cardiovasc Med. 2021;8:767064.","journal-title":"Front Cardiovasc Med."},{"key":"4502_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S42452-025-06888-4\/FIGURES\/2","volume":"7","author":"E Mollajan","year":"2025","unstructured":"Mollajan E, Yazdani S, Ghasemzadeh M, Mozhgani SH. miR-21 in cardiovascular disease: new insights and emerging therapeutic potential. Discover Applied Sciences. 2025;7:1\u201312. https:\/\/doi.org\/10.1007\/S42452-025-06888-4\/FIGURES\/2.","journal-title":"Discover Applied Sciences"},{"key":"4502_CR48","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1021\/acs.nanolett.8b02578","volume":"18","author":"T Bejerano","year":"2018","unstructured":"Bejerano T, Etzion S, Elyagon S, Etzion Y, Cohen S. Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction. Nano Lett. 2018;18:5885\u201391.","journal-title":"Nano Lett"},{"key":"4502_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.21037\/ATM-20-6073","volume":"9","author":"M Zheng","year":"2021","unstructured":"Zheng M, Wang M. A narrative review of the roles of the miR-15\/107 family in heart disease: lessons and prospects for heart disease. Ann Transl Med. 2021;9:66\u201366. https:\/\/doi.org\/10.21037\/ATM-20-6073.","journal-title":"Ann Transl Med"},{"key":"4502_CR50","doi-asserted-by":"publisher","first-page":"e12686","DOI":"10.7717\/PEERJ.12686\/SUPP-7","volume":"9","author":"D He","year":"2021","unstructured":"He D, Ruan ZB, Song GX, Chen GC, Wang F, Wang MX, et al. MiR-15a-5p regulates myocardial fibrosis in atrial fibrillation by targeting Smad7. PeerJ. 2021;9:e12686. https:\/\/doi.org\/10.7717\/PEERJ.12686\/SUPP-7.","journal-title":"PeerJ"},{"key":"4502_CR51","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s11010-024-05080-3","volume":"480","author":"F Cao","year":"2025","unstructured":"Cao F, Li Z, Ding W, Qv C, Zhao H. Exosomal miR-15a-5p from cardiomyocytes promotes myocardial fibrosis. Mol Cell Biochem. 2025;480:1701\u201313.","journal-title":"Mol Cell Biochem"},{"key":"4502_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-016-0216-5","volume":"15","author":"A Maimaiti","year":"2016","unstructured":"Maimaiti A, Maimaiti A, Yang Y, Ma Y. MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells. Lipids Health Dis. 2016;15:1\u201310.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"4502_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.22088\/IJMCM.BUMS.13.3.325","volume":"13","author":"R Azar Bahadori","year":"2024","unstructured":"Azar Bahadori R, Shabani D, Arjmandrad E, Kazerani M, Rohani M, Ramazani Karim Z, et al. Circulating miRNA-106b-5p as a potential biomarker for coronary artery disease. Int J Mol Cell Med. 2024;13(3):325\u201336. https:\/\/doi.org\/10.22088\/IJMCM.BUMS.13.3.325.","journal-title":"Int J Mol Cell Med"},{"key":"4502_CR54","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/EURHEARTJ\/EHQ369","volume":"32","author":"A Haghikia","year":"2011","unstructured":"Haghikia A, Missol-Kolka E, Tsikas D, Venturini L, Brundiers S, Castoldi M, et al. Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J. 2011;32:1287\u201397. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHQ369.","journal-title":"Eur Heart J"},{"key":"4502_CR55","doi-asserted-by":"publisher","first-page":"7662","DOI":"10.3390\/IJMS21207662","volume":"21","author":"L Jiang","year":"2020","unstructured":"Jiang L, Liang J, Huang W, Wu Z, Paul C, Wang Y. Strategies and challenges to improve cellular programming-based approaches for heart regeneration therapy. Int J Mol Sci. 2020;21:7662. https:\/\/doi.org\/10.3390\/IJMS21207662.","journal-title":"Int J Mol Sci"},{"key":"4502_CR56","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/NATURE11739","volume":"492","author":"A Eulalio","year":"2012","unstructured":"Eulalio A, Mano M, Ferro MD, Zentilin L, Sinagra G, Zacchigna S, et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012;492:376\u201381. https:\/\/doi.org\/10.1038\/NATURE11739.","journal-title":"Nature"},{"key":"4502_CR57","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/S41569-018-0036-6","volume":"15","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto H, Olson EN, Bassel-Duby R. Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol. 2018;15:585\u2013600. https:\/\/doi.org\/10.1038\/S41569-018-0036-6.","journal-title":"Nat Rev Cardiol"},{"key":"4502_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-49901-x","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liu S, Liang Y, He Y, Li Q, Zhan J, et al. Single dose of intravenous miR199a-5p delivery targeting ischemic heart for long-term repair of myocardial infarction. Nat Commun. 2024;15:1\u201317. https:\/\/doi.org\/10.1038\/s41467-024-49901-x.","journal-title":"Nat Commun"},{"key":"4502_CR59","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/cvr\/cvw174","volume":"111","author":"R Navickas","year":"2016","unstructured":"Navickas R, Gal D, Laucevi\u010dius A, Taparauskaite A, Zdanyte M, Holvoet P. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review. Cardiovasc Res. 2016;111:322\u201337. https:\/\/doi.org\/10.1093\/cvr\/cvw174.","journal-title":"Cardiovasc Res"},{"key":"4502_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2020.04.014","author":"E Kayvanpour","year":"2020","unstructured":"Kayvanpour E, Gi W-T, Sedaghat-Hamedani F, Lehmann DH, Frese KS, Haas J, et al. microRNA neural networks improve diagnosis of acute coronary syndrome (ACS). J Mol Cell Cardiol. 2020. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.04.014.","journal-title":"J Mol Cell Cardiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04502-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04502-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04502-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:44:17Z","timestamp":1764611057000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04502-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4502"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04502-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all study participants. The Ethics Committee and Institutional Review Boards of all participating centers approved the study protocol, including the collection and study of clinical data and biomaterials. The lead ethics approval was obtained from the Ethics Committee of the University of Heidelberg (approval reference: S-100\/2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"670"}}